Solicitor general to back Merck at Supreme Court in Fosamax pre-emption case

The solicitor general has been a major voice on pre-emption, generally backing the view that FDA decisions protect pharma from state legal challenges. Now, as the Supreme Court gears up for Merck's appeal in the Fosamax liability litigation, the feds are preparing to support the company's claim that pre-emption should protect it.